A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects

NCT00397566 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: HIV Integrase Inhibitor (BMS-707035)

Sponsor

Bristol-Myers Squibb